Exact Sciences Acquires Preventiongenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients
Exact Sciences Acquires Preventiongenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients
01/10/22, 12:03 AM
Location
madisonIndustry
science and engineering
information technology
Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases.
Company Info
Location
Madison, Wisconsin, United States
Company info
At Exact Sciences, our mission is to eradicate cancer and the suffering it causes — through tests that help prevent it, detect it earlier, and guide its successful treatment.
We're hiring! Our organization offers something for everyone, at all stages of careers and from all backgrounds. Let's take on cancer, together.